FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063161 [Registered on: 26/02/2024] Trial Registered Prospectively
Last Modified On: 23/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [HEALTH EDUCATION INTERVENTION]  
Study Design  Other 
Public Title of Study   Effectiveness of Human Papilloma Virus vaccine health education on knowledge, attitude and practice among school going students of two schools in Manipur: A Non-Randomized Control Trial 
Scientific Title of Study   Effectiveness of Human Papilloma Virus vaccine health education on knowledge, attitude and practice among school going students of two schools in Manipur: A Non-Randomized Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sneha Dhali 
Designation  Post Graduate Trainee, Department of Community Medicine 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Community Medicine ,Regional Institute of Medical sciences, Lamphelpat,Imphal,Manipur
Room-219,1st Floor, Kundolei Ladies PG Hostel,Regional Institute Of Medical Sciences, Lamphelpat,Imphal,Manipur
Imphal West
MANIPUR
795004
India 
Phone  9836933422  
Fax    
Email  dr.sdhali.96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. H. Sanayaima Devi 
Designation  Professor and Head of the Department, Department of Community Medicine 
Affiliation  Regional Institute of Medical Sciences 
Address  Department Of Community Medicine, Regional Institute of Medical Sciences, Lamphelpat, Imphal West, Manipur
Wangkhei Lourembam Leikai, Near Durga Puja Lampak, Imphal East-795005
Imphal East
MANIPUR
795004
India 
Phone  8575016616  
Fax    
Email  drsnanahj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sneha Dhali 
Designation  Post Graduate Trainee, Department of Community Medicine 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Community Medicine, Regional Institute of Medical Sciences, Lamphelpat, Imphal
ROOM-219,1ST FLOOR, KUNDOLEI LADIES PG HOSTEL,REGIONAL INSTITUTE OF MEDICAL SCIENCES, LAMPHELPAT,IMPHAL,MANIPUR
Imphal West
MANIPUR
795004
India 
Phone  9836933422  
Fax    
Email  dr.sdhali.96@gmail.com  
 
Source of Monetary or Material Support  
Sneha Dhali (Principal Investigator),Department of Community Medicine, Regional Institute of Medical sciences, Lamphelpat, Imphal, Manipur 
 
Primary Sponsor  
Name  Sneha Dhali 
Address  Department of Community Medicine, Regional Institute of Medical Sciences, Imphal, Manipur 
Type of Sponsor  Other [Principal Investigator] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sneha Dhali  Two Schools  Imphal West
Imphal West
MANIPUR 
09836933422

dr.sdhali.96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
RESEARCH ETHICS BOARD RIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Apparently healthy 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Health Education  Various domains about the HPV virus, its effects on human body, HPV vaccine and its benefits and other related topics will be covered under the different sessions and will be divided and covered 
Comparator Agent  No Intervention   No intervention will be provided 
 
Inclusion Criteria  
Age From  11.00 Year(s)
Age To  15.00 Year(s)
Gender  Both 
Details  Students belonging to grade VII, VIII and IX 
 
ExclusionCriteria 
Details  Students who were not present on the first day of data collection. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Knowledge, attitude and practice regarding the HPV vaccination   Baseline and 3 months  
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="372"
Sample Size from India="372" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Prior to study initiation and after obtaining ethical approval, a written permission will be sought from the principals of both schools to conduct the study. Verbal assent will be obtained from the students. The purpose and the procedure of the study will be then explained to the study participants thoroughly. Participants will be administered an envelope  which will contain a questionnaire which they will be asked to fill in completely. The medical students will be reassured about their anonymity at the time of questionnaire administration. No name will be collected during this entire procedure. After obtaining the consent, the students will be asked to sit in an ordered manner of atleast one hand distance and asked to fill in the questionnaire and time allotment will be 30 mins , during which  thorough invigilation will be done so as to avoid any sort of discussion between them.  Students will be briefed about the importance of honest answer and not to copy from each other. The invigilator will remain present throughout the study period in the class. If any doubts arise, they will be clarified at the end of the follow-up period.

After completion of all the 4 sets of the questionnaire form, Intervention will be given just after in the form of health education which will include lecture cum group discussion and  the second session of the intervention will be  done after a period of 1 week which would include audio visual aids,video shows, pamphlet distribution and a quiz program. The study participants for the intervention group and the control group will be requested to gather again after 3 months for follow-up. The same questionnaire that is used for pre-test will be administered again after 3 months for post-test.

Purposive sampling method will be used in this study. Details of the schools will be taken from the Directorate of Education, Manipur. Out of the eligible schools, 2 schools will be selected purposively. One school will be allocated in the intervention group, and one school will be allocated to the control group. From each of the selected school, 62 students will be selected from each standard (VII, VIII, IX) using simple random sampling from the attendance registers to acquire total sample size of 372 (186 from each school).

 
Close